top of page

AI Powered Drug Discovery and Manufacturing

CONFERENCE 2020

February 27 - 28, 2020

MIT, Cambridge, MA

please2.png

Agenda

Day 1

9:00am 

9:10am 

9:30am 

10:00am

10:30am

11:00am

12:00pm

1:30pm

3:00pm

3:30pm

5:30pm

4:00pm

8:00am 

Breakfast

 

Welcome 

Innovation in Pharma Industry Phillip Sharp (MIT), Richard Young (MIT)

Active Disruption in Pharma R&D Mathai Mammen (Janssen) 

Discovering New Therapeutic Molecules with ML Regina Barzilay (MIT), Jim Collins (MIT)

 

Break

 

Technical Session: Drug Discovery: Learning from Chemistry 

Session Chair: Rafael Gomez-Bombarelli (MIT)

Speakers:

Tommi Jaakkola (MIT): "De-novo Molecular Design" 

Alan Aspuru-Guzik (U of Toronto): "Do Androids Dream of Therapeutic Molecules?" 

Frank Noe (UF Berlin): "Deep Learning Molecular Thermodynamics and Kinetics" 

Posters (Lunch Provided) 

 

Panel: Real Cases of AI Implementation: Lessons Learned and Next Steps  

Moderator: Gisbert Schneider (ETH Zurich)

Participants: Brandon Allgood (Integral Health), Hugo Ceulemans (Janssen), Ola Engkvist (AZ), Miriam Mathea (BASF), Pat Walters (Relay), Lee Herman (Sunovion) 

 

Break

 

From Wearables to Invisibles! Dina Katabi (MIT)

Panel: New Era of Data Collection for Discovery and Manufacturing

Moderator: Najat Khan (Janssen)

Participants: Juan Alvarez (Merck), Djork-Arne Clevert (Bayer), Anne Fischer (Darpa), Steven Kearnes (Google), Joe Tucker (Pfizer), Jose Duca (Novartis), Li Xing (WuXi AppTec)

Adjourn

Day 2

9:00am

10:30am

12:00pm

1:30pm

2:45pm

3:00pm

3:45pm

4:00pm

5:00pm

8:00am

Breakfast 

Panel: Funding AI research: VC perspective

Moderator: Bob Langer (MIT)

Participants: Noubar Afeyan (Flagship Pioneering), Vik Bajaj (Foresite Capital Management), Ari Brettman (Blackstone Life Sciences), Vinod Khosla (Khosla Ventures), Amir Nashat (Polaris), Nicole Stata (Boston Seed Capital)

 

Technical Session: Drug Discovery: Learning from Biology

Session Chair: Zavain Dar (Lux Capital)

Speakers:

Rafael Gomez-Bombarelli (MIT): "Machine Learning Sequence-to-property Relationships for Design and Synthesis of Therapeutic Peptides"

Anne Carpenter (Broad): "Accelerating Drug Discovery Through the Power of Microscopy Images"

Andrew Senior (DeepMind): "AlphaFold: Improved Protein Structure Prediction Using Potentials from Deep Learning."

Peter Sorger (Harvard): "High Dimensional Tissue Imaging and Machine Learning to Enable Next Generation Precision Medicine"  

 

Posters (Lunch Provided)

 

Technical Session: Make It

Session Chair: Ryan White (J-Clinic, MIT)

Speakers:

Connor Coley (MIT): "Data-driven Modeling of Chemical Reactivity"

Klavs Jensen (MIT): "AI-Assisted Development and Manufacturing of Small Molecules"  

Cenk Undey (Amgen): “Advancing the Potential of Artificial Intelligence in the Bio/Pharmaceutical Industry 4.0 Revolution:  Amgen’s Journey from Advanced Automation towards Intelligent Systems"

 

Break

 

Panel: Regulatory Issues in AI adoption

Moderator:  Patrick Swann (Amgen)

Participants: Thomas O’Connor (FDA), Jack Chu (CAI), Jeffrey Baker (FDA), Rob Guenard (Biogen)

 

Break

 

Fireside Chat Susan Hockfield (MIT), Shahram Ebadollahi (Novartis), Erik Brynjolfsson (MIT)

 

Best Poster Awards and Closing Remarks

bottom of page